If you could vote on Brexit now which option would you choose?

COVID-19 pill rollout stymied by shortages as omicron rages

Two brand-new COVID-19 pills that were supposed to be an important weapon against the pandemic in the U.S. are in short supply and have played little role in the fight against the omicron wave of infections. The problem, in part, is that production is still being ramped up and the medicines can take anywhere from five to eight months to manufacture. While the supply is expected to improve dramatically in the coming months, doctors are clamoring for the pills now, not just because omicron is causing an explosion of cases but because two antibody drugs that were once the go-to treatments don’t work as well against the variant.

Scientific Viewpoint - January 13, 2022

View the full story here: https://apnews.com/article/coronavirus-pandemic-science-business-health-pandemics-b2d1051842df779dfa6122f824bd0377